News & Trends - MedTech & Diagnostics
A healthcare sector gap in ESG reporting should be a wake-up call
The Australian healthcare sector is one of the lower performers in environmental, social and governance (ESG) reporting, according to Australia’s peak body on climate and health, the Climate and Health Alliance (CAHA).
While ASX200 companies increasingly acknowledge ESG performance as a value driver within their businesses, the ESG Reporting Trends report revealed that out of the 14 ASX200 companies in the healthcare sector none had a ‘comprehensive’ ESG reporting rating and only 5 had a ‘detailed’ reporting rating, highlighting a sector-wide gap.
CEO of the Climate and Health Alliance, Roland Sapsford, said “The revelation that the healthcare sector is lagging behind mining companies, utilities, and real estate sectors in reporting on serious ESG risks is deeply concerning.
“We all experienced the anxiety of not knowing how supply chain disruptions could affect everyday goods during the pandemic. Many people’s health was also potentially at risk with shortages of medications highlighting how important it is for the sector to manage these risks.”
Emerging ESG trends impacting the medtech sector
Among the fourteen (14) ASX 200 companies in the healthcare sector, Ansell, Fisher & Paykel Healthcare, Nanosonics, Ramsay Health Care and Sonic Healthcare had a ‘detailed’ reporting rating – the highest rating in the healthcare sector – while the remaining none (9) companies had moderate-basic ESG reporting ratings, with three (3) companies not reporting at all.
Mr Sapsford continued “The health sector continues to operate under considerable strain, the health workforce is struggling, and we continue to face unexpected and unprecedented challenges from extreme weather conditions.
“The idea that the health sector, of all sectors, is lacking transparency around how it manages risks – whether to supply chains, workforce, the pandemic or climate change – should send shock waves through the community and lead investors to ask hard questions.”
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals
Medicines Australia and AusBiotech CEOs set agenda for the new year
Liz de Somer, CEO of Medicines Australia, and Bek Cassidy, CEO of AusBiotech, look back on the key accomplishments of […]
MoreNews & Trends - MedTech & Diagnostics
MTAA and PTA CEOs voice outlook for the year ahead
Ian Burgess, CEO of the Medical Technology Association of Australia (MTAA), and Dean Whiting, CEO of Pathology Technology Australia (PTA), […]
MoreNews & Trends - Pharmaceuticals
Scathing report exposes Labor’s mismanagement of the PBS
The Labor Government’s administration of the $19.5 billion Pharmaceutical Benefit Scheme (PBS) has been found to be only “partly effective”. […]
More